Oppenheimer Warns Raptor Pharma Could Fall By ~50%, Suggests 'Sell While You Can'
July 06, 2015 at 09:32 AM EDT
In a report published Monday, Oppenheimer analyst Christopher Marai downgraded the rating on Raptor Pharmaceutical Corp. (NASDAQ: RPTP) ...